SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who started this subject2/6/2002 8:09:47 PM
From: IRWIN JAMES FRANKEL   of 10280
 
Revised Valuation - Per share #'s ijfrankel
(51/M/St. Louis, Mo) 2/6/02 7:52 pm
Product --- Per Share
Xopenex ---- 23.11
Xopenex MDI 9.70
Clarinex 6.29
Allegra - US 7.70
Allegra - XUS 3.08
Soltara ----- 20.12
Formoterol 8.98
Zyrtec - 0.36
zopiclone 10.78
s-oxibutytin 4.31
cash --- 11.60
TOTAL --- 86.67

LESS:

Debt -- 16.16

Soltara Launch 3.21

Total deductions 19.37

Per Share Value 86.67

Shares 77,900,000
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News